Infographic | April 15, 2019

Biologic Drug Substance And Drug Product Preferred Provider Use

Source: ISR Reports

In Q4, 2018 ISR asked 124 outsourcers of biologic drug substance and 138 outsourcers of biologic drug product about their organizations’ use of preferred providers. The data show the majority of respondents from both categories work at companies that use a preferred provider approach to outsourcing, and average about four CMOs on their lists.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online